AIM: To monitor molecular heterogeneity among the clinical isolates of group A Streptococcus (GAS) from north India by Vir and emm typing. METHODS AND RESULTS:GAS isolates, 31 from pharyngitis and nine from rheumatic fever (RF)/rheumatic heart disease (RHD) patients were differentiated into 16 Vir types (VT). These isolates were further discriminated into 23 emm types. Most of emm types were Vir type specific, except few (7.5%), which revealed different Vir types within same emm type. The most prevalent emm type found was emm 49 (15%) followed by 7.5% of emm 69, emm 71 and emm 75 which were different from emm type distribution reported from south India. CONCLUSIONS: Analysis of data revealed 40% heterogeneity by Vir typing and 57.5% by emm typing among GAS isolates which is significant in view of small number of isolates studied. SIGNIFICANCE OF IMPACT OF THE STUDY: The molecular study for the first time demonstrates different emm types prevalent and circulating in northern region of India and such data may help in selection of types for vaccine development.
RCT Entities:
AIM: To monitor molecular heterogeneity among the clinical isolates of group A Streptococcus (GAS) from north India by Vir and emm typing. METHODS AND RESULTS:GAS isolates, 31 from pharyngitis and nine from rheumatic fever (RF)/rheumatic heart disease (RHD) patients were differentiated into 16 Vir types (VT). These isolates were further discriminated into 23 emm types. Most of emm types were Vir type specific, except few (7.5%), which revealed different Vir types within same emm type. The most prevalent emm type found was emm 49 (15%) followed by 7.5% of emm 69, emm 71 and emm 75 which were different from emm type distribution reported from south India. CONCLUSIONS: Analysis of data revealed 40% heterogeneity by Vir typing and 57.5% by emm typing among GAS isolates which is significant in view of small number of isolates studied. SIGNIFICANCE OF IMPACT OF THE STUDY: The molecular study for the first time demonstrates different emm types prevalent and circulating in northern region of India and such data may help in selection of types for vaccine development.
Authors: Andrew C Steer; Graham Magor; Adam W J Jenney; Joseph Kado; Michael F Good; David McMillan; Michael Batzloff; Jonathan R Carapetis Journal: J Clin Microbiol Date: 2009-06-10 Impact factor: 5.948
Authors: Debra E Bessen; W Michael McShan; Scott V Nguyen; Amol Shetty; Sonia Agrawal; Hervé Tettelin Journal: Infect Genet Evol Date: 2014-10-30 Impact factor: 3.342
Authors: Vivek Sagar; René Bergmann; Andreas Nerlich; David J McMillan; D Patric Nitsche Schmitz; Gursharan S Chhatwal Journal: Clin Vaccine Immunol Date: 2012-09-12
Authors: Bela Shah; Meenakshi Sharma; Rajesh Kumar; K N Brahmadathan; Vinod Joseph Abraham; Rajan Tandon Journal: Indian J Pediatr Date: 2012-09-02 Impact factor: 1.967
Authors: R Kumar; A Chakraborti; A K Aggarwal; H Vohra; V Sagar; V Dhanda; Y P Sharma; S Majumdar; N Hoe; R M Krause Journal: Indian J Med Res Date: 2012 Impact factor: 2.375
Authors: A C Bowen; T Harris; D C Holt; P M Giffard; J R Carapetis; P T Campbell; J McVERNON; S Y C Tong Journal: Epidemiol Infect Date: 2016-02-01 Impact factor: 4.434